Area of research
Genetics · Cancer Research
Research interest
Research focused on Cancer research and Dabrafenib, with related work in Homeobox, Trametinib, Isocitrate dehydrogenase. Notable publications include 'TERT and DNMT1 expression predict sensitivity to decitabine in gliomas', 'MEOX2 homeobox gene promotes growth of malignant gliomas', and 'Single-nucleus chromatin accessibility reveals intratumoral epigenetic heterogeneity in IDH1 mutant gliomas'.
BRAF/MEK Inhibition Induces Cell State Transitions Boosting Immune Checkpoint Sensitivity in BRAF <sup>V600E</sup> -mutant Glioma
<i>MEOX2</i> homeobox gene promotes growth of malignant gliomas
STEM-15. THERAPY-INDUCED CHANGES BY BRAF AND MEK INHIBITORS IN BRAF V600E-MUTATED GLIOMA MODELS PROVIDE POTENTIAL NOVEL THERAPEUTIC OPPORTUNITIES
EXTH-42. COMBINATION OF MAPK PATHWAY INHIBITORS AND IMMUNE CHECKPOINT BLOCKADE IN BRAF-MUTANT HIGH-GRADE GLIOMA
LGG-05. GENERATION OF NOVEL MOUSE MODELS FOR BRAF V600E MUTANT GLIOMAGENESIS TO GAIN MECHANISTIC INSIGHTS INTO TUMOR FORMATION AND PROGRESSION
<i>MEOX2</i> homeobox gene promotes growth of malignant gliomas
TERT and DNMT1 expression predict sensitivity to decitabine in gliomas
Single-nucleus chromatin accessibility reveals intratumoral epigenetic heterogeneity in IDH1 mutant gliomas